is being presented by Dr. Joy Frestedt, President & CEO, with Frestedt Incorporated and airs on Thursday, June 10th, 2010. For more details or to register for this event, please visit our site at www.fxconferences.com
Managing risk is an evolving specialty, and is becoming more critical thanks to increasingly strict global regulatory requirements for risk evaluation and management. No longer is simply recording and reporting adverse events sufficient to demonstrate due diligience for ensuring consumer safety. The need to proactively track, trend and attempt to predict risk-related issues is now critical and is a required part of every drug, device and biological design program.
This audio conference presentation looks at current trends in risk management, and how it can impact development budgets and timelines for drug and device manufacturers. Our speaker also shares valuable insight on practical activities and the training required to effectively reduce costs and speed timelines when conducting risk evaluation and mitigation strategies.
